Scientific Hub of Applied Research in Emerging Medical science & technology
https://shareme.joinjet.org/ojs/index.php/shareme
<p>SHAREme- Scientific Hub of Applied Research in Emerging Medical science & technology is a leading international journal for publication of new ideas, the state of the applied research results and fundamental advances in all aspects of Medical Science and technology started in 2022. SHAREme is a scholarly open access, peer reviewed international journal with a primary objective to provide the academic community and industry for the submission of their original research.<br /><strong>Publication fee Rs.2000</strong></p>en-US[email protected] (Editor in Chief)[email protected] (Jeya Prakash R)Thu, 02 Apr 2026 08:22:22 +0000OJS 3.3.0.8http://blogs.law.harvard.edu/tech/rss60Development and Comprehensive Summative Evaluation of An Evidence-Based Caretaker's Handbook For Home-Based Physiotherapy And Activities Of Daily Living In Geriatric Neurological Patients
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/88
<p><strong>Background:</strong> Diabetic neuropathy (DN) is a prevalent complication of diabetes mellitus leading to significant sensory and motor deficits. Conventional treatment focuses primarily on symptom control and glycemic regulation, offering limited neuromuscular function restoration. Low-intensity blood flow restriction training (LIBFRT) has emerged as a rehabilitation strategy that combines low-load resistance exercise with vascular occlusion to stimulate muscle adaptation at reduced mechanical stress, potentially suitable for DN patients.</p> <p><strong>Objective: </strong>This review aims to systematically synthesize existing evidence concerning the efficacy and safety of LIBFRT in DN management, evaluating intervention parameters, diagnostic criteria, clinical outcomes, and adverse events.</p> <p><strong>Methods: </strong>A comprehensive literature search identified 12 interventional studies (2010–2025) involving patients with clinically and neuro physiologically confirmed DN undergoing LIBFRT.Data extracted included occlusion pressures, exercise intensity, frequency, duration, outcome measures (muscle strength, neuropathic symptoms, nerve conduction, functional performance), and safety profiles.</p> <p><strong>Results:</strong> Protocols typically employed 20–40% 1-RM with individualized limb occlusion pressures (40–60% arterial occlusion) conducted 2–3sessions weekly for 4–8weeks. Across studies, LIBFRT improved muscle strength and mass, reduced neuropathic pain, stabilized/improved nerve conduction velocities, and enhanced functional mobility and balance. Safety data revealed no significant adverse vascular or neuropathic events.</p> <p><strong>Conclusion:</strong> LIBFRT appears to be a safe and effective adjunct in DN rehabilitation, promoting neuromuscular recovery and symptom alleviation. It merits incorporation into multidisciplinary care, but further large-scale RCTs with longer follow-up are warranted to refine protocols and confirm sustained benefits. Background: Parkinson disease and stroke among elderly patients pose high needs due to the need of home-based rehabilitation. The family caregivers offer most of the care but do not have the comprehensive and evidence based resources. The research findings show that trained caregivers enhance patient outcomes by 2040 percent[1][2][3] and lower healthcare expenses by 27-40 percent[1]. This is a project that will synthesize all the research evidence into a convenient handbook to assist the caretakers.</p> <p><strong>Purpose:</strong> To prepare a draft and summative assessment of a comprehensive and evidence-based handbook to support family members in the recovery of their stroke or ADL-assisted geriatric patients with stroke or Parkinson disease.</p> <p><strong>Methods:</strong> PubMed, Cochrane, EMBASE, PEDro, CINAHL were searched using systematic literature review (1999-2025) to select 30 high quality studies (12 systematic review/meta-analysis, 8 RCT, 10 observational/validation). Evidence summarized into 7-section handbook based on Functional Independence Measure (FIM) level[29]. Clinician/educator review of 8 experts. Pilot testing on 15 caregivers.</p> <p>Findings Final handbook will include 124 pages and 48,000+ words. Seven key overall sections with detailed contents in all the areas of rehabilitation. Expert panel ratings (5-point Likert): Content Accuracy 4.6/5.0, Clarity 4.5/5.0, Clinical Utility 4.7/5.0, Safety Emphasis 4.8/5.0. Pilot implementation: the confidence of caregivers rose dramatically (3.2 to 7.8/10)[6], safety incidents reduced 75 percent[5], patient functional outcomes enhanced[2]. A high level of satisfaction and a high rate of recommendation was reported among all caregivers.</p> <p><strong>Conclusions:</strong> This clinical handbook fills important gaps in resources in home rehabilitation. FIM-level organization, condition-specific adaptations, safety protocols, and useful templates help caregivers to provide effective, safe, and scalable home-based rehabilitation. Extensive distribution via medical institutions, schools and online highly encouraged[23].</p>Aisiri P Kottur, Sindhura K, Toral Jagdish Vaja
Copyright (c) 2026
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/88Sat, 04 Apr 2026 00:00:00 +0000Chimeric Antigen Receptor (CAR)-T cell Therapy in Hematological Malignancies: Current Advances, Challenges, And Future Perspectives
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/95
<p>Chimeric antigen receptor T-cell (CAR-T) therapy represents a groundbreaking advancement in cancer immunotherapy and has significantly transformed the treatment landscape for hematological malignancies. This innovative adoptive cellular therapy involves the genetic engineering of a patient’s T lymphocytes to express synthetic receptors capable of recognizing specific tumor-associated antigens on malignant cells. By enabling T cells to directly identify and eliminate cancer cells in a major histocompatibility complex-independent manner, CAR-T therapy has emerged as a highly effective therapeutic strategy for patients with relapsed or refractory hematologic cancers. In recent years, CAR-T therapies targeting antigens such as CD19 and B-cell maturation antigen (BCMA) have demonstrated remarkable clinical efficacy in diseases including acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. Several CAR-T cell products have received regulatory approval and have shown high overall response rates and durable remissions in heavily pretreated patients who previously had limited treatment options.</p> <p>Despite these encouraging outcomes, CAR-T therapy is associated with several limitations and safety concerns, including cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, antigen escape, complex manufacturing procedures, and high treatment costs. Ongoing research efforts are focused on improving CAR design, enhancing T-cell persistence, identifying novel tumor targets, and developing universal or allogeneic CAR-T cell platforms. Additionally, emerging strategies such as dual-target CAR-T cells, gene-editing technologies, and combination therapies with immune checkpoint inhibitors are being investigated to further improve therapeutic efficacy and reduce adverse effects. This review provides a comprehensive overview of CAR-T cell therapy, including its mechanism of action, structural design, clinical applications in hematological malignancies, approved CAR-T therapies, treatment-related toxicities, current challenges, and future perspectives in the evolving field of cancer immunotherapy.</p>Thota Lakshmi, Allankritha Sri, Akhila Ajith, Sayanolla Archana, A. Dhanush Kumar, Nandini Penchala
Copyright (c) 2026
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/95Thu, 16 Apr 2026 00:00:00 +0000Anticancer Activity of Barleria prionitis Leaf Ethanolic Extract against Dalton’s Lymphoma Ascites Induced Tumor in Mice
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/96
<p><strong>Background:</strong> Natural products remain a cornerstone in anticancer drug discovery. Barleria prionitis (Family: Acanthaceae) is traditionally used for various inflammatory and infectious conditions and possesses significant phytochemical diversity.</p> <p><strong>Objective:</strong> The present study aimed to evaluate the anticancer activity of ethanolic extract of Barleria prionitis leaves against Dalton’s Lymphoma Ascites (DLA)-induced tumor in mice.</p> <p><strong>Methods:</strong> DLA cells were inoculated intraperitoneally into Swiss albino mice. The ethanolic extract of B. prionitis leaves was administered orally at selected doses for 14 consecutive days. Antitumor activity was assessed by evaluating tumor volume, packed cell volume, viable and non-viable tumor cell count, body weight changes, mean survival time (MST), and percentage increase in life span (ILS). Hematological, biochemical, and antioxidant parameters were analyzed.</p> <p><strong>Results:</strong> Treatment with the extract significantly reduced tumor volume, viable cell count, and body weight gain compared to tumor control (p < 0.05). A significant increase in MST and ILS was observed. Hematological parameters were restored toward normal values. Antioxidant enzymes such as SOD and catalase were modulated, and lipid peroxidation was significantly reduced.</p> <p><strong>Conclusion: </strong>The ethanolic extract of Barleria prionitis leaves exhibits significant anticancer activity against DLA-induced lymphoma in mice, possibly mediated through antioxidant mechanisms, immune modulation, and apoptosis induction.</p>L.K. Shridharan, V. Suresh, N. Senthilkumar
Copyright (c) 2026
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/96Thu, 16 Apr 2026 00:00:00 +0000A Comparative Study of Traditional Vs. Triphasic Resistance Training on Speed and Explosive Power in Collegiate Football Players.
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/101
<h2 style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Background</span></h2> <p style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">This study compared a six-week triphasic resistance training (TRT) programme with a matched-volume traditional resistance training (TRAD) protocol to examine changes in speed and explosive lower-limb power among collegiate football players.</span></p> <h2 style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Aim</span></h2> <p style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">To evaluate feasibility and performance outcomes between triphasic and traditional resistance training methods.</span></p> <h2 style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Methods</span></h2> <p style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Eight male athletes (18–25 years) were randomly assigned to either group. Performance was assessed using the 10 m sprint, countermovement jump (CMJ), and Modified Illinois Change-of-Direction (MI-COD) tests. Feasibility metrics were also recorded.</span></p> <h2 style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Results</span></h2> <p style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">TRT showed greater improvements in CMJ (+5.4%), MI-COD (–3.9%), and sprint (–4.2%) compared with TRAD (<1%). Feasibility targets were fully achieved.</span></p> <h2 style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Conclusion</span></h2> <p style="text-align: justify; margin: 0cm 0cm 6.0pt 0cm;"><span lang="EN-MY" style="font-size: 11.0pt;">Triphasic resistance training produced larger improvements in speed, vertical jump, and change-of-direction ability compared with traditional training. The programme was feasible, well tolerated, and safe for collegiate football players. A larger randomized trial is recommended to confirm these findings.</span></p>Selvakumar B, Pinky Dutta, Shwetha Sasidharan
Copyright (c) 2026
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/101Thu, 16 Apr 2026 00:00:00 +0000Efficacy of Muscle Energy Technique and Neurodynamic Sliding Technique in Reducing Hamstring Tightness among College Students
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/98
<p><strong>Background</strong>: Hamstring tightness is a prevalent musculoskeletal concern among college students, often leading to functional impairments and increased injury risk. Muscle Energy Technique (MET) and Neurodynamic Sliding Technique (NDT) have been proposed as effective interventions to improve hamstring flexibility by targeting muscular and neural components.</p> <p><strong>Objective: </strong>To systematically review and synthesize evidence on the efficacy of MET and NDT in reducing hamstring tightness among college students.</p> <p><strong>Methods:</strong> A literature search was conducted across PubMed, Google Scholar, and Science Direct databases for randomized controlled trials and clinical studies focusing on MET and NDT in young adults. Studies published between 2010 and 2025 meeting predefined inclusion criteria were selected. Data on intervention protocols, outcome measures, and safety were extracted and analysed.</p> <p><strong>Results: </strong>A total of 15 articles met the inclusion criteria. Both MET and NDT demonstrated statistically significant improvements in hamstring flexibility, with NDT showing a slightly higher effect size. Intervention durations ranged from single sessions to six weeks, with consistent results supporting the safety and efficacy of both techniques.</p> <p><strong>Conclusions:</strong> Both MET and NDT are effective in reducing hamstring tightness, with NDT providing potentially more sustained improvements. Incorporating these techniques in rehabilitation protocols can optimize flexibility outcomes in college student populations.</p>Sabari Mani R, Sedhunivas R, Arnold Nikhilesh
Copyright (c) 2026
https://shareme.joinjet.org/ojs/index.php/shareme/article/view/98Fri, 17 Apr 2026 00:00:00 +0000